Analysis Of Needs For Enforcement Of Pfas In Articles And Chemical Products
Download Analysis Of Needs For Enforcement Of Pfas In Articles And Chemical Products PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Analysis Of Needs For Enforcement Of Pfas In Articles And Chemical Products book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages.
Analysis of needs for enforcement of PFAS in articles and chemical products
Available online: https://pub.norden.org/temanord2024-510/ Per- and polyfluoroalkyl substances (PFAS) are a large group of substances that have been widely used for decades due to their surface-active properties. However, their characteristic resistance to degradation in combination with other properties of concern for human health and the environment has resulted in regulatory actions such as restrictions towards this group of substances, in the EU and globally. Compliance with restrictions as well as enforcement by authorities is key to reduce intentional use of restricted PFAS in articles and chemical products. To analyse PFAS accurately, robust and reliable analytical methods are required. This report evaluates the current situation related to PFAS-analyses and enforcement (including challenges and needs) and propose measures/strategies to enable and/or improve enforcement of, and compliance with current and future, PFAS restrictions.
The cost of inaction
Author: Gretta Goldenman
language: en
Publisher: Nordic Council of Ministers
Release Date: 2019-03-17
PFAS (per and polyfluoroalkylsubstances) are known to be extremely difficult to degrade in the environment and to be bioaccumulative and toxic. Exposure to PFAS is suspected to increase the risk of adverse health effects, such as impacts on the thyroid gland, the liver, fat metabolism and the immune system. This study estimates the socioeconomic costs that may result from impacts on human health and the environment from the use of PFAS. Better awareness of the costs and problems associated with PFAS exposure will assist decision-makers and the general public to make more efficient and timely risk management decisions. Findings indicate that the costs are substantial, with annual health-related costs estimated to 2.8 – 4.6 billion EUR for the Nordic countries and 52 – 84 billion EUR for all EEA countries. Overall non-health costs are estimated at 46 million – 11 billion EUR for the Nordic countries.Upon request the excel spreadsheets used for the monetarisation and valuation in this report can also be provided along with a guidance on how to use the estimation of costs for value transfer. Please contact any of the consultants or members of the steering group from the Swedish Chemicals Agency or the Danish Environmental Protection Agency if you are interested in receiving these excel spreadsheets.
Polyfluorinated Chemicals and Transformation Products
Author: Thomas P. Knepper
language: en
Publisher: Springer Science & Business Media
Release Date: 2011-09-21
Due to their unparalleled effectiveness and efficiency, polyfluorinated chemicals (PFC) have become essential in numerous technical applications. However, many PFCs brought to market show limited biodegradability, and their environmental persistence combined with toxic and bioaccumulative potential have become a matter of concern in some instances. This volume highlights the synthesis of PFCs, focusing on substances with improved application and environmental properties, which are a challenge for synthetic chemists. Further, modern mass spectrometric techniques for the detection and identification of biotransformation products of PFCs are described. The sorption and leaching behavior of PFC in soil is also addressed in order to predict their fate in the environment. Several contributions discuss the monitoring of PFCs in European surface, ground and drinking waters, treatment options for PFC removal from drinking water, occurrence in food, and the human biomonitoring of PFCs.